Yuanyuan Cheng

681 total citations
16 papers, 550 citations indexed

About

Yuanyuan Cheng is a scholar working on Molecular Biology, Biomedical Engineering and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yuanyuan Cheng has authored 16 papers receiving a total of 550 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Biomedical Engineering and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yuanyuan Cheng's work include Nanoplatforms for cancer theranostics (7 papers), Photodynamic Therapy Research Studies (4 papers) and MicroRNA in disease regulation (2 papers). Yuanyuan Cheng is often cited by papers focused on Nanoplatforms for cancer theranostics (7 papers), Photodynamic Therapy Research Studies (4 papers) and MicroRNA in disease regulation (2 papers). Yuanyuan Cheng collaborates with scholars based in China, New Zealand and United States. Yuanyuan Cheng's co-authors include Qian Chen, Yinsong Wang, Hongli Chen, Guoyun Wan, Mengwen Li, Qiqing Zhang, Xiaoying Yang, Zhaoyang Guo, Yuanyuan Liu and Jia Song and has published in prestigious journals such as SHILAP Revista de lepidopterología, ACS Nano and Advanced Functional Materials.

In The Last Decade

Yuanyuan Cheng

16 papers receiving 546 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuanyuan Cheng China 10 304 251 132 105 98 16 550
Ali Tarighatnia Iran 11 298 1.0× 153 0.6× 152 1.2× 111 1.1× 71 0.7× 32 576
Kuirong Mao China 11 242 0.8× 208 0.8× 141 1.1× 74 0.7× 77 0.8× 25 492
Wen Ma China 13 273 0.9× 191 0.8× 78 0.6× 93 0.9× 119 1.2× 32 552
Wan Su Yun South Korea 16 411 1.4× 241 1.0× 225 1.7× 81 0.8× 131 1.3× 25 726
Minglu Zhou China 14 257 0.8× 276 1.1× 165 1.3× 53 0.5× 91 0.9× 29 603
Xupeng Mu China 15 309 1.0× 378 1.5× 225 1.7× 55 0.5× 93 0.9× 37 694
Wenshe Sun China 12 413 1.4× 235 0.9× 138 1.0× 175 1.7× 102 1.0× 21 689
Xinzhu Shan China 9 322 1.1× 257 1.0× 172 1.3× 176 1.7× 41 0.4× 9 585
Yue Geng United States 11 298 1.0× 221 0.9× 173 1.3× 42 0.4× 173 1.8× 19 629
Marina Poettler Austria 11 151 0.5× 203 0.8× 140 1.1× 72 0.7× 116 1.2× 14 545

Countries citing papers authored by Yuanyuan Cheng

Since Specialization
Citations

This map shows the geographic impact of Yuanyuan Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuanyuan Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuanyuan Cheng more than expected).

Fields of papers citing papers by Yuanyuan Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuanyuan Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuanyuan Cheng. The network helps show where Yuanyuan Cheng may publish in the future.

Co-authorship network of co-authors of Yuanyuan Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Yuanyuan Cheng. A scholar is included among the top collaborators of Yuanyuan Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuanyuan Cheng. Yuanyuan Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Zhai, Zihan, Yuanyuan Cheng, Yue Wang, et al.. (2025). Multi-functionalized probiotics through layer-by-layer coating with tannic acid-Mg2+ and casein phosphopeptide complexes for preventing ulcerative colitis. Materials Today Bio. 31. 101621–101621. 5 indexed citations
2.
Cheng, Yuanyuan, Ming Hong, Hongli Chen, et al.. (2024). An effective drug-free hydrogel for accelerating the whole healing process of bacteria-infected wounds. Biomaterials Science. 13(3). 758–776. 3 indexed citations
3.
Wu, Jiaxin, Ran You, Qian Chen, et al.. (2024). An injectable adhesive hydrogel for photothermal ablation and antitumor immune activation against bacteria-associated oral squamous cell carcinoma. Acta Biomaterialia. 186. 229–245. 5 indexed citations
6.
Cheng, Yuanyuan, et al.. (2022). Versatile Red Blood Cells for Triple‐Negative Breast Cancer Treatment via Stepwise Photoactivations. Advanced Healthcare Materials. 12(3). e2201690–e2201690. 13 indexed citations
7.
Wan, Guoyun, Haijiao Wang, Qian Wang, et al.. (2021). Gene augmented nuclear-targeting sonodynamic therapy via Nrf2 pathway-based redox balance adjustment boosts peptide-based anti-PD-L1 therapy on colorectal cancer. Journal of Nanobiotechnology. 19(1). 347–347. 41 indexed citations
8.
Cheng, Yuanyuan, Xiaoyan Li, Qian Wu, et al.. (2021). ADAM10 is involved in the oncogenic process and chemo-resistance of triple-negative breast cancer via regulating Notch1 signaling pathway, CD44 and PrPc. Cancer Cell International. 21(1). 32–32. 31 indexed citations
9.
Cheng, Yuanyuan, Qian Chen, Zhaoyang Guo, et al.. (2020). An Intelligent Biomimetic Nanoplatform for Holistic Treatment of Metastatic Triple-Negative Breast Cancer via Photothermal Ablation and Immune Remodeling. ACS Nano. 14(11). 15161–15181. 139 indexed citations
10.
Cheng, Yuanyuan, Weiqi Bao, & Qian Wu. (2020). Cerebral hemispheric glioblastoma with PNET-like morphology and histone H3.3 G34 mutation in younger patients: Report of three rare cases and diagnostic pitfalls. SHILAP Revista de lepidopterología. 63(2). 262–262. 6 indexed citations
11.
Wang, Shuang, et al.. (2020). Silencing of Long Noncoding RNA LINC00324 Interacts with MicroRNA-3200-5p to Attenuate the Tumorigenesis of Gastric Cancer via Regulating BCAT1. Gastroenterology Research and Practice. 2020. 1–12. 15 indexed citations
12.
Cheng, Zhifei, Yuanyuan Cheng, Qian Chen, et al.. (2020). Self-assembly of pentapeptides into morphology-adaptable nanomedicines for enhanced combinatorial chemo-photodynamic therapy. Nano Today. 33. 100878–100878. 63 indexed citations
13.
Wan, Guoyun, Yuanyuan Cheng, Jia Song, et al.. (2019). Nucleus-targeting near-infrared nanoparticles based on TAT peptide-conjugated IR780 for photo-chemotherapy of breast cancer. Chemical Engineering Journal. 380. 122458–122458. 110 indexed citations
14.
Cheng, Yuanyuan, Lili Tao, Jiawen Xu, et al.. (2013). CD44/Cellular prion protein interact in multidrug resistant breast cancer cells and correlate with responses to neoadjuvant chemotherapy in breast cancer patients. Molecular Carcinogenesis. 53(9). 686–697. 44 indexed citations
15.
Hu, Xiao, Yong Bao, Li Zhang, et al.. (2010). [A prospective randomized study of the radiotherapy volume for limited-stage small cell lung cancer: a preliminary report].. PubMed. 13(7). 691–9. 1 indexed citations
16.
Cao, Xi-Xi, Jingda Xu, Jiawen Xu, et al.. (2009). RACK1 promotes breast carcinoma proliferation and invasion/metastasis in vitro and in vivo. Breast Cancer Research and Treatment. 123(2). 375–386. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026